DDX39B and non-small cell lung carcinoma: Taken together, our data describe a novel mechanism by which TRIM28/DDX39B/ECAD axis contributes to the EMT reprogramming and metastasis in NSCLC and targeting DDX39B by artesunate is an effective and promising therapeutic approach for the treatment of NSCLC.